Finance
Beta
search
Search or ask
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
SHL
Research
SHL:ASX
check_indeterminate_small
Sonic Healthcare Ltd
A$18.79
arrow_upward
+0.43%
(
+0.080
) 1D
Jun 3, 4:10:28 PM GMT+10 · AUD
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
Earnings
Financials
insights_auto
Generating top insights for SHL...
Open
A$18.73
High
A$18.83
Low
A$18.45
Mkt. cap
9.29B
Avg. vol.
1.73M
Volume
1.37M
Dividend
5.75%
Quarterly dividend
A$0.27
Ex-dividend date
Sep 3, 2025
P/E ratio
16.99
52-wk high
A$29.24
52-wk low
A$18.26
EPS
A$1.11
Shares outstanding
494.24M
No. of employees
45K
Open
A$18.73
High
A$18.83
Low
A$18.45
Mkt. cap
9.29B
Avg. vol.
1.73M
Volume
1.37M
Dividend
5.75%
Quarterly dividend
A$0.27
Ex-dividend date
Sep 3, 2025
P/E ratio
16.99
52-wk high
A$29.24
52-wk low
A$18.26
EPS
A$1.11
Shares outstanding
494.24M
No. of employees
45K
Related stocks
CSL
CSL Ltd
A$92.24
-0.35%
arrow_downward
TWE
Treasury Wine Estates Ltd
A$4.12
+0.24%
arrow_upward
SOL
Washington H. Soul Pattinson and Co Ltd
A$43.19
+0.37%
arrow_upward
COH
Cochlear Ltd
A$95.10
-1.70%
arrow_downward
News stories
From sources across the web
Kalkine Media
·
1 day ago
Healthcare Stocks Across ASX 300 Draw Fresh Interest
Profile
Sonic Healthcare Limited is a Sydney-based, Australian company that provides laboratory services, pathology, radiology services and primary care medical services.
Wikipedia
Show all
About Sonic Healthcare Ltd
CEO
Colin S. Goldschmidt M.D.
Employees
45K
Founded
1934
Headquarters
Sydney, New South Wales, Australia
Sector
Health care provider
Website
sonichealthcare.com
Previous reports
All values in AUD
Loading Previous Earnings...
Income statement
Balance sheet
Cash flow
Income statement
Revenue
Net income
calendar_month
Quarterly
Quarterly
Annual
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.49B
2.49B
2.72B
2.72B
Cost of goods sold
1.66B
1.66B
1.84B
1.84B
Cost of revenue
1.66B
1.66B
1.84B
1.84B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
68.15M
68.15M
84.51M
84.51M
Operating expense
579.99M
579.99M
636.48M
636.48M
Total operating expenses
2.24B
2.24B
2.48B
2.48B
Operating income
250.22M
250.22M
244.41M
244.41M
Other non operating income
-
-
-
-
EBT including unusual items
201.00M
201.00M
188.44M
188.44M
EBT excluding unusual items
203.41M
203.41M
192.32M
192.32M
Income tax expense
56.72M
56.72M
49.90M
49.90M
Effective tax rate
28.22%
28.22%
26.48%
26.48%
Other operating expenses
305.81M
305.81M
334.84M
334.84M
Net income
138.46M
138.46M
131.24M
131.24M
Net profit margin
5.56%
5.56%
4.82%
4.82%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-46.80M
-46.80M
-52.09M
-52.09M
Net interest expenses
-46.80M
-46.80M
-52.09M
-52.09M
Depreciation and amortization charges
182.38M
182.38M
192.74M
192.74M
EBITDA
456.25M
456.25M
461.55M
461.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Research
edit_square
New thread
notes_spark
Thread history
close
Collapse
expand_content
Expand
add
Add Tool
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer